Stockholders' Equity Attributable to Parent in USD of BriaCell Therapeutics Corp. from Q2 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
BriaCell Therapeutics Corp. quarterly Stockholders' Equity Attributable to Parent history and change rate from Q2 2020 to Q2 2023.
  • BriaCell Therapeutics Corp. Stockholders' Equity Attributable to Parent for the quarter ending 31 Jul 2023 was -$3,777,181.000, a 137% decline year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

BriaCell Therapeutics Corp. Quarterly Stockholders' Equity Attributable to Parent (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2023 -$3,777,181 -$14,106,113 -1.4% 31 Jul 2023 10-K 25 Oct 2023
Q1 2023 -$5,892,342 -$15,850,794 -1.6% 30 Apr 2023 10-Q 14 Jun 2023
Q4 2022 -$1,280,586 -$17,706,284 -1.1% 31 Jan 2023 10-Q 14 Jun 2023
Q3 2022 $10,334,332 +$8,750,555 +5.5% 31 Oct 2022 10-Q 16 Mar 2023
Q2 2022 $10,328,932 -$17,342,789 -62.7% 31 Jul 2022 10-K 25 Oct 2023
Q1 2022 $9,958,452 30 Apr 2022 10-Q 14 Jun 2023
Q4 2021 $16,425,698 31 Jan 2022 10-Q 14 Jun 2023
Q3 2021 $1,583,777 31 Oct 2021 10-Q 16 Mar 2023
Q2 2021 $27,671,721 +$30,412,473 31 Jul 2021 10-K 25 Oct 2023
Q2 2020 -$2,740,752 31 Jul 2020 10-K 28 Oct 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.